European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE): A randomised control trial
Open Access
- 28 September 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Trials
- Vol. 9 (1), 55
- https://doi.org/10.1186/1745-6215-9-55
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chainsKidney International, 2008
- Plasma exchange for myeloma kidney: cast(s) away?Kidney International, 2008
- Efficient Removal of Immunoglobulin Free Light Chains by Hemodialysis for Multiple MyelomaJournal of the American Society of Nephrology, 2007
- Lipid Changes and Statins in Chronic Renal InsufficiencyJournal of the American Society of Nephrology, 2006
- Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective studyBlood, 2006
- International uniform response criteria for multiple myelomaLeukemia, 2006
- Plasma Exchange When Myeloma Presents as Acute Renal FailureAnnals of Internal Medicine, 2005
- PAD combination therapy (PS‐341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myelomaBritish Journal of Haematology, 2005
- Renal Failure in Multiple MyelomaArchives of Internal Medicine, 1998
- Renal Failure in Multiple MyelomaArchives of Internal Medicine, 1990